The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
Open accessAbstract
Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome and the leading cause of chronic liver disease in the Western world. Twenty per cent of NAFLD individuals develop chronic hepatic inflammation (non-alcoholic steatohepatitis, NASH) associated with cirrhosis, portal hypertension and hepatocellular carcinoma, yet the causes of progression from NAFLD to NASH remain obscure. Here, we show that the NLRP6 and NLRP3 inflammasomes and the effector protein IL-18 negatively regulate NAFLD/NASH progression, as well as multiple aspects of metabolic syndrome via modulation of the gut microbiota. Different mouse models reveal that inflammasome-deficiency-associated changes in the configuration of the gut microbiota are associated with exacerbated hepatic steatosis and inflammation through influx of TLR4 and TLR9 agonists into the portal circulation, leading to enhanced hepatic tumour-necrosis factor (TNF)-α expression that drives NASH progression. Furthermore, co-housing of inflammasome-deficient mice with wild-type mice results in exacerbation of hepatic steatosis and obesity. Thus, altered interactions between the gut microbiota and the host, produced by defective NLRP3 and NLRP6 inflammasome sensing, may govern the rate of progression of multiple metabolic syndrome-associated abnormalities, highlighting the central role of the microbiota in the pathogenesis of heretofore seemingly unrelated systemic auto-inflammatory and metabolic disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Either in patients with NASH or animal models, the expression of inflammasome components was increased, indicating the potential role in the pathogenesis of liver injury [226,227,288,289,290,291].”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [226]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“LPS-mediated activation of KCs via TLR4 leading to MyD88-dependent activation of NF-kB, production of proinflammatory cytokines and subsequent liver injury have also been demonstrated for both MASH(214) and ASH(215).”
From The liver as a central "hub" of the immune system: pathophysiological implications (2025) · cites this paper as [214]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Animal studies have demonstrated a direct role of altered intestinal microbiota in steatosis,15 NASH(16), fibrosis17 and liver cancer.18”
From Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signalling (2023) · cites this paper as [16]
In the citing paper
“In NAFLD models, lack of inflammasomes has been demonstrated to select a pathogenetic microbiota which was associated with a more severe degree of liver injury [226].”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [226]
In the citing paper
“These results indicate that complex interactions between the diet, the innate immunity, bacteria and intestinal function occurs in the development of NASH [226,227], and similar observations were obtained in experimental models of HCC development [285,286,287].”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [226]
In the citing paper
“Co-housing wildtype mice with mice prone to MASH led to increased disease severity in wildtype mice, presumably due to a transfer of fecal microbiota (204).”
From Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH) (2023) · cites this paper as [204]
In the citing paper
“In the MCD diet model, the microbiota has a key role in NASH exacerbation as demonstrated by experiments, in which co-housing transmitted NASH risk and antibiotics reduced NASH risk65.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [65]
In the citing paper
“Functional studies utilizing co-housing and faecal transplantation have provided evidence that dysbiosis is a transmissible driver of liver disease development and progression 65,89.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [65]
In the citing paper
“Similarly, dysbiosis represented a transmissible risk factor in a genetic NASH model in which NASH was triggered by inflammasome deficiency; co-housing of dysbiotic inflammasome-deficient mice with control mice resulted in the development of NASH in control mice65.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [65]
In the citing paper
“Association of bacterial composition with many diseases has been observed, including immune, inflammatory, and metabolic phenotypes.”
From The Gut Microbiome Contributes to a Substantial Proportion of the Variation in Blood Lipids (2015) · cites this paper as [5]
In the citing paper
“Disruption of the murine inflammasomes (see box 1) is associated with an increase in Bacteroidetes and reduction in Firmicutes and results in severe hepatic steatosis and inflammation.41”
From The gut microbiota and host health: a new clinical frontier (2016) · cites this paper as [41]
In the citing paper
“the NLRP6 and NLRP3 inflammasomes may exert protective effects against NAFLD/NASH through modulation of the gut microbiota.181”
From Interaction between microbiota and immunity in health and disease (2020) · cites this paper as [181]
In the citing paper
“Dysbiosis has been observed in mice deficient for inflammasomes components, including NLRP6, ASC, caspase-1, and IL-18 [131,132,133,134].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [134]
In the citing paper
“The Muc2-KO mouse possesses a distinct gut-associated bacterial community that is influenced by its altered genetic and immune states, as has been shown in other genetic knockout mouse models.4,53–55”
From Using Corticosteroids to Reshape the Gut Microbiome: Implications for Inflammatory Bowel Diseases (2015) · cites this paper as [54]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
Self-citationDesign and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491 · cited 1×
“Tlr9 –/– mice have been described in another repor”
BackgroundMartinon, F., Burns, K., & Tschopp, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00599-3 · Cited by 6,066
A role for mitochondria in nlrp3 inflammasome activation
Zhou, R., Yazdi, A. S., Menu, P., & Tschopp, J. (2011) · Nature · doi:10.1038/nature09663 · Cited by 5,602
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026
Ludwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M., Manini, R., Natale, S., Vanni, E., Villanova, N., Melchionda, N., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50161 · Cited by 2,728
Thioredoxin-interacting protein links oxidative stress to inflammasome activation
Zhou, R., Tardivel, A., Thorens, B., Choi, I., & Tschopp, J. (2010) · Nature Immunology · doi:10.1038/ni.1831 · Cited by 2,708
Cited by
Sorted by citations
Items 501–600 of 1,011
How functional foods play critical roles in human health
Pang, G., Xie, J., Chen, Q., & Zhi-he, H. (2012) · Food Science and Human Wellness · doi:10.1016/j.fshw.2012.10.001 · Cited by 134
Gut Microbiome and Multiple Sclerosis
Bhargava, P., & Mowry, E. M. (2014) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-014-0492-2 · Cited by 129
Wang, Y., Chen, C., Chen, J., Sang, T., Peng, H., Lin, X., Zhao, Q., Chen, S., Eling, T. E., & Wang, X. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102322 · Cited by 130
Mucosal immunity in liver autoimmunity: A comprehensive review
Trivedi, P. J., & Adams, D. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.06.013 · Cited by 129
Oxidative Stress and Redox Signaling in the Pathophysiology of Liver Diseases
Mooli, R. G. R., Mukhi, D., & Ramakrishnan, S. K. (2022) · Comprehensive physiology · doi:10.1002/cphy.c200021 · Cited by 134
NLRP6: A Multifaceted Innate Immune Sensor
Levy, M., Shapiro, H., Thaiss, C. A., & Elinav, E. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.01.001 · Cited by 127
Self-citationMolecular Mechanisms and New Treatment Strategies for Non-Alcoholic Steatohepatitis (NASH)
Takaki, A., Kawai, D., & Yamamoto, K. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15057352 · Cited by 127
Khan, A., Ding, Z., Ishaq, M. H., Bacha, A. S., KHAN, I. A., Hanif, A., Li, W., & Guo, X. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.56214 · Cited by 130
Schoeler, M., Ellero‐Simatos, S., Birkner, T., Mayneris‐Perxachs, J., Olsson, L. M., Brolin, H., Löber, U., Kraft, J. D., Polizzi, A., Martí-Navas, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41074-3 · Cited by 135
Physiology and pathophysiology of liver lipid metabolism
Ponziani, F. R., Pecere, S., Gasbarrini, A., & Ojetti, V. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2015.1056156 · Cited by 133
Inflammasomes and intestinal inflammation
Zmora, N., Levy, M., Pevsner-Fishcer, M., & Elinav, E. (2017) · Mucosal Immunology · doi:10.1038/mi.2017.19 · Cited by 130
Self-citationColonic Microbiota Encroachment Correlates With Dysglycemia in Humans
Chassaing, B., Raja, S. M., Lewis, J. D., Srinivasan, S., & Gewirtz, A. T. (2017) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2017.04.001 · Cited by 130
Yang, M. J., Qi, X., Li, N., Kaifi, J. T., Chen, S., Wheeler, A. A., Kimchi, E. T., Ericsson, A. C., Rector, R. S., Staveley-O’Carroll, K. F., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-35861-1 · Cited by 129
Metagenome and metabolism: the tissue microbiota hypothesis
Burcelin, R., Sérino, M., Chabo, C., Garidou, L., Pomié, C., Courtney, M., Amar, J., & Bouloumié, A. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12157 · Cited by 130
Diet, Microbiota, Obesity, and NAFLD: A Dangerous Quartet
Machado, M. V., & Cortez‐Pinto, H. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040481 · Cited by 129
Multi ‘omic data integration: A review of concepts, considerations, and approaches
Santiago-Rodríguez, T. M., & Hollister, E. B. (2021) · Seminars in Perinatology · doi:10.1016/j.semperi.2021.151456 · Cited by 132
Betrapally, N. S., Gillevet, P. M., & Bajaj, J. S. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.073 · Cited by 123
Power of metabolomics in biomarker discovery and mining mechanisms of obesity
Zhang, A., Sun, H., & Wang, X. (2012) · Obesity Reviews · doi:10.1111/obr.12011 · Cited by 123
Update on primary sclerosing cholangitis
Karlsen, T. H., & Boberg, K. M. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.03.015 · Cited by 123
Systems biology in hepatology: approaches and applications
Mardinoğlu, A., Borén, J., Smith, U., Uhlén, M., & Nielsen, J. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0007-8 · Cited by 127
The avian gut microbiota: Diversity, influencing factors, and future directions
Sun, F., Chen, J., Liu, K., Tang, M., & Yang, Y. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.934272 · Cited by 126
Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis
Ghetti, F. D. F., de Oliveira, D. G., de Oliveira, J. M., Ferreira, L. E. V. V. D. C., Cesar, D. E., & Moreira, A. P. B. (2017) · European Journal of Nutrition · doi:10.1007/s00394-017-1524-x · Cited by 125
Relevance of the NLRP3 Inflammasome in the Pathogenesis of Chronic Liver Disease
Wu, X., Dong, L., Lin, X., & Li, J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01728 · Cited by 122
Ding, Y., Yanagi, K., Cheng, C., Alaniz, R. C., Lee, K., & Jayaraman, A. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.01.029 · Cited by 125
Yu, L., Hong, W., Lu, S., Li, Y., Guan, Y., Weng, X., & Feng, Z. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.780496 · Cited by 126
Thelemann, C., Eren, R. O., Coutaz, M., Brasseit, J., Bouzourène, H., Rosa, M., Duval, A., Lavanchy, C., Mack, V., Mueller, C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086844 · Cited by 122
Depression and chronic liver diseases: are there shared underlying mechanisms?
Huang, X., Liu, X., & Yu, Y. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00134 · Cited by 121
The NLRP3 Inflammasome as a Novel Player of the Intercellular Crosstalk in Metabolic Disorders
Benetti, E., Chiazza, F., Patel, N. S. A., & Collino, M. (2013) · Mediators of Inflammation · doi:10.1155/2013/678627 · Cited by 122
Janssen, A. W. F., Houben, T., Katiraei, S., Dijk, W., Boutens, L., van der Bolt, N., Wang, Z., Brown, J. M., Hazen, S. L., Mandard, S., et al. (2017) · Journal of Lipid Research · doi:10.1194/jlr.m075713 · Cited by 121
Inflammasome activation has an important role in the development of spontaneous colitis
Zhang, J., Fu, S., Sun, S., Li, Z., & Guo, B. (2014) · Mucosal Immunology · doi:10.1038/mi.2014.1 · Cited by 122
How Inflammation Impinges on NAFLD: A Role for Kupffer Cells
Duarte, N., Coelho, I. C., Patarrão, R. S., Almeida, J. I., Penha-Gonçalves, C., & Macedo, M. P. (2015) · BioMed Research International · doi:10.1155/2015/984578 · Cited by 120
Rovira‐Llopis, S., Apostolova, N., Bañuls, C., Muntané, J., Rocha, M., & Víctor, V. M. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7313 · Cited by 125
Glyphosate-induced lipid metabolism disorder contributes to hepatotoxicity in juvenile common carp
Liu, J., Dong, C., Zhai, Z., Tang, L., & Wang, L. (2020) · Environmental Pollution · doi:10.1016/j.envpol.2020.116186 · Cited by 120
Zheng, D., Kern, L., & Elinav, E. (2020) · Immunology · doi:10.1111/imm.13293 · Cited by 125
Self-citationYang, J., Lim, S. Y., Ko, Y. S., Lee, H. Y., Oh, S. W., Kim, M. G., Cho, W. Y., & Jo, S. K. (2019) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy172 · Cited by 119
Li, K., Dan, Z., Gesang, L., Wang, H., Zhou, Y., Du, Y., Ren, Y., Shi, Y., & Nie, Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155863 · Cited by 120
Li, Y., Liu, T., Yan, C., Xie, R., Guo, Z., Wang, S., Zhang, Y., Li, Z., Wang, B., & Cao, H. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00347 · Cited by 120
Standardised animal models of host microbial mutualism
Macpherson, A. J., & McCoy, K. D. (2014) · Mucosal Immunology · doi:10.1038/mi.2014.113 · Cited by 122
Paneth cell α-defensins and enteric microbiota in health and disease
Nakamura, K., Sakuragi, N., Takakuwa, A., & Ayabe, T. (2015) · Bioscience of Microbiota Food and Health · doi:10.12938/bmfh.2015-019 · Cited by 128
Zhang, Z., Ran, C., Ding, Q., Liu, H.-L., Xie, M., Yang, Y., Xie, Y.-D., Gao, C., Zhang, H., & Zhou, Z. (2019) · Communications Biology · doi:10.1038/s42003-019-0526-z · Cited by 118
Torre, S. D. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.572490 · Cited by 125
Microbiota, immunoregulatory old friends and psychiatric disorders
Rook, G. A. W., Raison, C. L., & Lowry, C. A. (2014) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4939-0897-4_15 · Cited by 117
Gut Microbiota in Intestinal and Liver Disease
Jones, R. M., & Neish, A. S. (2020) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-030320-095722 · Cited by 117
Mu, H., Zhou, Q., Yang, R., Tang, W., Li, H.-X., Wang, S., Li, J., Chen, W., & Dong, J. (2021) · Food Research International · doi:10.1016/j.foodres.2021.110240 · Cited by 116
Ding, C., Zhao, Y., Shi, X., Zhang, N., Zu, G., Li, Z., Zhou, J., Gao, D., Lv, L., Tian, X., et al. (2016) · Scientific Reports · doi:10.1038/srep28734 · Cited by 115
Gut microbiota and obesity-associated osteoarthritis
Liu, Y., Ding, W., Wang, H., Dai, L. L., Zong, W. H., Wang, Y. Z., Bi, J., Han, W., & Dong, G. (2019) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2019.05.009 · Cited by 117
Impact of Melatonin on Skeletal Muscle and Exercise
Stacchiotti, A., Favero, G., & Rodella, L. F. (2020) · Cells · doi:10.3390/cells9020288 · Cited by 116
Zhang, B., Jiang, M., Zhao, J., Song, Y., Du, W., & Shi, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.841703 · Cited by 119
Inflammasomes and Metabolic Disorders: Old Genes in Modern Diseases
Robbins, G. R., Wen, H., & Ting, J. P. ‐. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.03.029 · Cited by 118
Role of NLRP3 Inflammasome Activation in Obesity-Mediated Metabolic Disorders
Wani, K., AlHarthi, H., Alghamdi, A. A., Sabico, S., & Al‐Daghri, N. M. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18020511 · Cited by 118
Nicolson, G. L., & Ash, M. E. (2013) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2013.11.010 · Cited by 117
The Liver at the Nexus of Host-Microbial Interactions
Macpherson, A. J., Heikenwälder, M. F., & Ganal-Vonarburg, S. C. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.10.016 · Cited by 114
Gut-liver axis signaling in portal hypertension
Simbrunner, B., Mandorfer, M., Trauner, M., & Reiberger, T. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i39.5897 · Cited by 113
Liu, X., Sun, R., Li, Z., Xiao, R., Lv, P., Sun, X., Olson, M. A., & Gong, Y. (2021) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2021.109019 · Cited by 115
Peng, H., Pan, L., Ran, S., Wang, M., Huang, S., Zhao, M., Cao, Z., Yao, Z., Xu, L., Yang, Q., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1083032 · Cited by 115
Lv, T., Fan, X., He, C., Zhu, S., Xiong, X., Yan, W., Liu, M., Xu, H., Shi, R., & He, Q. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103159 · Cited by 114
Dixon, A., Robertson, K., Yung, A. E., Que, M. S., Randall, H., Wellalagodage, D., Cox, T., Robertson, D., Chi, C., & Sun, J. (2020) · Current Hypertension Reports · doi:10.1007/s11906-020-01080-y · Cited by 118
Drożdż, K., Nabrdalik, K., Hajzler, W., Kwiendacz, H., Gumprecht, J., & Lip, G. Y. H. (2021) · Nutrients · doi:10.3390/nu14010103 · Cited by 115
Lau, H. C.-H., Zhang, X., & Yu, J. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01089-1 · Cited by 126
Schneider, K. M., Bieghs, V., Heymann, F., Hu, W., Yildiz, D., Liao, L., Frissen, M., Ludwig, A., Gaßler, N., Pabst, O., et al. (2015) · Hepatology · doi:10.1002/hep.27982 · Cited by 112
Gut microbiota and liver disease
Goel, A., Gupta, M. C., & Aggarwal, R. (2014) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12556 · Cited by 112
Immunity, microbiota and kidney disease
Knauf, F., Brewer, J. R., & Flavell, R. A. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0118-7 · Cited by 112
Self-citationGut microbiota and immunity relevance in eubiosis and dysbiosis
Al-Rashidi, H. E. (2021) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2021.10.068 · Cited by 116
Compan, V., Martín‐Sánchez, F., Baroja‐Mazo, A., López‐Castejón, G., Gomez, A. I., Verkhratsky, A., Brough, D., & Pelegrı́n, P. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1301676 · Cited by 116
Links between Dietary Protein Sources, the Gut Microbiota, and Obesity
Madsen, L., Myrmel, L. S., Fjære, E., Liaset, B., & Kristiansen, K. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.01047 · Cited by 110
Gut–liver on a chip toward an in vitro model of hepatic steatosis
Lee, S. Y., & Sung, J. H. (2018) · Biotechnology and Bioengineering · doi:10.1002/bit.26793 · Cited by 113
Nettleton, J. E., Cho, N. A., Klančič, T., Nicolucci, A. C., Shearer, J., Borgland, S. L., Johnston, L., Ramay, H. R., Tuplin, E. W. N., Chleilat, F., et al. (2020) · Gut · doi:10.1136/gutjnl-2018-317505 · Cited by 115
Role of Caspase-1 in the Pathogenesis of Inflammatory-Associated Chronic Noncommunicable Diseases
Molla, M. D., Akalu, Y., Geto, Z., Dagnew, B., Ayelign, B., & Shibabaw, T. (2020) · Journal of Inflammation Research · doi:10.2147/jir.s277457 · Cited by 119
IKKα negatively regulates ASC-dependent inflammasome activation
Martin, B. N., Wang, C., Willette‐Brown, J., Herjan, T., Gulen, M. F., Zhou, H., Bulek, K., Franchi, L., Sato, T., Alnemri, E. S., et al. (2014) · Nature Communications · doi:10.1038/ncomms5977 · Cited by 116
Modeling human nonalcoholic fatty liver disease (NAFLD) with an organoids-on-a-chip system
Wang, Y., Wang, H., Deng, P., Tao, T., Liu, H., Wu, S., Chen, W., & Qin, J. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c00682 · Cited by 109
Hygiene and other early childhood influences on the subsequent function of the immune system
Rook, G. A. W., Lowry, C. A., & Raison, C. L. (2015) · Brain Research · doi:10.1016/j.brainres.2014.04.004 · Cited by 109
Segovia-Miranda, F., Morales-Navarrete, H., Kücken, M., Moser, V., Seifert, S., Repnik, U., Rost, F., Brosch, M., Hendricks, A., Hinz, S., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0660-7 · Cited by 109
An Update on PYRIN Domain-Containing Pattern Recognition Receptors: From Immunity to Pathology
Ratsimandresy, R. A., Dorfleutner, A., & Stehlik, C. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00440 · Cited by 114
Cooperative Microbial Tolerance Behaviors in Host-Microbiota Mutualism
Ayres, J. S. (2016) · Cell · doi:10.1016/j.cell.2016.05.049 · Cited by 114
Panasevich, M. R., Meers, G. M.-E., Linden, M. A., Booth, F. W., Perfield, J. W., Fritsche, K. L., Wankhade, U. D., Chintapalli, S. V., Shankar, K., Ibdah, J. A., et al. (2017) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00015.2017 · Cited by 109
Ma, Y., Chen, K., Lv, L., Wu, S., & Guo, Z. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108753 · Cited by 111
The Gut-liver Axis in Immune Remodeling: New insight into Liver Diseases
Yang, X., Lu, D., Zhuo, J., Lin, Z., Yang, M., & Xu, X. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.46405 · Cited by 113
Fecal microbiota transplantation: effectiveness, complexities, and lingering concerns
Pamer, E. G. (2014) · Mucosal Immunology · doi:10.1038/mi.2013.117 · Cited by 113
Kotsiliti, E., Leone, V., Schuehle, S., Govaere, O., Li, H., Wolf, M. J., Horvatic, H., Bierwirth, S., Hundertmark, J., Inverso, D., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.04.037 · Cited by 108
Self-citationIntestinal Dysbiosis Amplifies Acetaminophen-Induced Acute Liver Injury
Schneider, K. M., Elfers, C., Ghallab, A., Schneider, C. V., Galvez, E. J. C., Mohs, A., Gui, W., Candels, L. S., Wirtz, T. H., Zuehlke, S., et al. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2020.11.002 · Cited by 108
Self-citationMagee, N. S., Zou, A., & Zhang, Y. (2016) · BioMed Research International · doi:10.1155/2016/5170402 · Cited by 114
Apigenin ameliorates HFD-induced NAFLD through regulation of the XO/NLRP3 pathways
Lv, Y., Gao, X., Luo, Y., Fan, W., Shen, T., Ding, C., Yao, M., Song, S., & Yan, L. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.05.015 · Cited by 108
Patel, S., Behara, R., Swanson, G. B., Forsyth, C. B., Voigt, R. M., & Keshavarzian, A. (2015) · Biomolecules · doi:10.3390/biom5042573 · Cited by 115
Brown, J. M., & Hazen, S. L. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r116.765388 · Cited by 108
Role of Oxidative Stress in Liver Disorders
Conde de la Rosa, L., Goicoechea, L., Torres, S., Garcia-Ruiz, C., & Fernandez-Checa, J. C. (2022) · Livers · doi:10.3390/livers2040023 · Cited by 107
Pika Population Density Is Associated with the Composition and Diversity of Gut Microbiota
Li, H., Qu, J., Li, T., Li, J., Lin, Q., & Li, X. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00758 · Cited by 107
Gut microbiota as an “invisible organ” that modulates the function of drugs
Li, X., Liu, L., Cao, Z., Li, W., Li, H., Lu, C. C., Yang, X., & Liu, Y. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109653 · Cited by 107
Complex Roles of Caspases in the Pathogenesis of Inflammatory Bowel Disease
Becker, C., Watson, A. J. M., & Neurath, M. F. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.11.035 · Cited by 107
Ge, C., Yu, R., Xu, M., Li, P., Fan, C., Li, J., & Kong, L. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.11.043 · Cited by 106
Gao, M., Ma, Y., & Liu, D. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1125-1 · Cited by 108
From Gut Microbiota through Low-Grade Inflammation to Obesity: Key Players and Potential Targets
Vetrani, C., Nisio, A. D., Paschou, S. Α., Barrea, L., Muscogiuri, G., Graziadio, C., Savastano, S., & Colao, A. (2022) · Nutrients · doi:10.3390/nu14102103 · Cited by 108
The Role of Intestinal Bacteria Overgrowth in Obesity-Related Nonalcoholic Fatty Liver Disease
Ferolla, S. M., Armiliato, G. N. D. A., Couto, C. A., & Ferrari, T. C. A. (2014) · Nutrients · doi:10.3390/nu6125583 · Cited by 104
Therapeutic Manipulation of the Microbiome in IBD: Current Results and Future Approaches
Hansen, J. J., & Sartor, R. B. (2015) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-014-0042-7 · Cited by 109
He, X., Gao, J., Hou, H., Qi, Z., Chen, H., & Zhang, X. (2019) · Environmental Science & Technology · doi:10.1021/acs.est.9b05131 · Cited by 106
Impact of gut microbiota on the fly’s germ line
Elgart, M., Stern, S., Salton, O., Gnainsky, Y., Heifetz, Y., & Soen, Y. (2016) · Nature Communications · doi:10.1038/ncomms11280 · Cited by 106
Gut microbiome and liver disease
Betrapally, N. S., Gillevet, P. M., & Bajaj, J. S. (2016) · Translational research · doi:10.1016/j.trsl.2016.07.005 · Cited by 106
Li, T.-T., Liu, Y.-Y., Wan, X.-Z., Huang, Z.-R., Liu, B., & Zhao, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103075 · Cited by 103
Qin, X., & Pan, J. (2015) · Health Economics · doi:10.1002/hec.3217 · Cited by 103
The colonic microbiota in health and disease
Shanahan, F. (2012) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32835a3493 · Cited by 104
Zheng, P., Li, Y., Wu, J., Zhang, H., Huang, Y., Tan, X., Pan, J., Duan, J., Liang, W., Yin, B., et al. (2019) · Advanced Science · doi:10.1002/advs.201901441 · Cited by 104
Metadata
- Authors
- Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W. Z., Strowig, T., Thaiss, C. A., Kau, A. L., Eisenbarth, S. C., Jurczak, M. J., Camporez, J.-P., Shulman, G. I., Gordon, J. I., Hoffman, H. M., & Flavell, R. A.
- Affiliations
- Yale University (US)
- Washington University in St. Louis (US)
- Howard Hughes Medical Institute (US)
- University of California San Diego (US)
- Corresponding author
- Flavell, Richard A.
- ORCID
- Venue
- Nature
- Published
- 2012-02
- Volume
- 482
- Issue
- 7384
- Pages
- 179-185
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3276682
- OpenAlex
- W2144275312
- Cited by
- 2,435
- References
- 41
- Citations by year
- 2026: 83 · 2025: 103 · 2024: 137 · 2023: 165 · 2022: 158 · 2021: 182 · 2020: 215 · 2019: 188 · 2018: 197 · 2017: 184 · 2016: 172 · 2015: 195 · 2014: 181 · 2013: 185 · 2012: 85
- FWCI
- 154.13
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Crohn's and Colitis Foundation
- U.S. Public Health Service (K08A1085038)
- National Heart, Lung, and Blood Institute (T32HL007974)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK45735, R01-DK40936, R01DK040936, U24DK059635, R01DK076674, R24DK085638, P30DK045735)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, NLRP3 inflammasome, NLRP6 inflammasome, IL-18, gut dysbiosis, metabolic syndrome, obesity, hepatic steatosis, liver inflammation, TLR4, TLR9, TNF-α, Porphyromonadaceae, host-microbiota interactions, autoinflammatory disease
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Carrier Proteins, Choline, Colon, Cytoskeletal Proteins, Disease Models, Animal, Fatty Liver, Inflammation, Male, Methionine, Mice, Inbred C57BL, Obesity, Receptors, Cell Surface, RNA, Ribosomal, 16S, Tumor Necrosis Factor-alpha, Disease Progression, Interleukin-18, Apoptosis Regulatory Proteins, Toll-Like Receptor 4, Toll-Like Receptor 9, Mice, CARD Signaling Adaptor Proteins, Metagenome, Inflammasomes, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
